These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15185124)

  • 1. WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.
    Church MW; Blakley BW; Burgio DL; Gupta AK
    J Assoc Res Otolaryngol; 2004 Sep; 5(3):227-37. PubMed ID: 15185124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
    Church MW; Kaltenbach JA; Blakley BW; Burgio DL
    Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
    Kaltenbach JA; Church MW; Blakley BW; McCaslin DL; Burgio DL
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):493-500. PubMed ID: 9374173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the protective effects of amifostine against cisplatin-induced toxicity.
    Hussain AE; Blakley BW; Nicolas M; Balderston J
    J Otolaryngol; 2003 Oct; 32(5):294-7. PubMed ID: 14974858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of amifostine: from cytoprotectant to therapeutic agent.
    Santini V; Giles FJ
    Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
    Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
    Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low-dose regimen of cisplatin before high-dose cisplatin potentiates ototoxicity.
    Harrison RT; DeBacker JR; Bielefeld EC
    Laryngoscope; 2015 Feb; 125(2):E78-83. PubMed ID: 25267530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ototoxicity of 12 mg/kg cisplatin in the Fischer 344/NHsd rat using multiple dosing strategies.
    Harrison RT; Seiler BM; Bielefeld EC
    Anticancer Drugs; 2016 Sep; 27(8):780-6. PubMed ID: 27467178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Audiological findings in a Phase I protocol investigating the effect of WR 2721, high-dose cisplatin and radiation therapy in patients with locally advanced cervical carcinoma.
    Rubin JS; Wadler S; Beitler JJ; Haynes H; Rozenblit A; McGill F; Goldberg G; Runowicz C
    J Laryngol Otol; 1995 Aug; 109(8):744-7. PubMed ID: 7561498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amifostine otoprotection to cisplatin ototoxicity: a guinea pig study using otoacoustic emission distortion products (DPOEA) and scanning electron microscopy].
    Hyppolito MA; de Oliveira AA; Lessa RM; Rossato M
    Braz J Otorhinolaryngol; 2005; 71(3):268-73. PubMed ID: 16446928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
    Jamesdaniel S; Rathinam R; Neumann WL
    Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
    Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
    Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
    Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
    Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin protects against cisplatin-induced hearing loss in mice.
    Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
    Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity.
    Olgun Y; Kırkım G; Kolatan E; Kıray M; Bagrıyanık A; Olgun A; Kızmazoglu DC; Ellıdokuz H; Serbetcıoglu B; Altun Z; Aktas S; Yılmaz O; Günerı EA
    Laryngoscope; 2014 Mar; 124(3):760-6. PubMed ID: 23900991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.
    Marina N; Chang KW; Malogolowkin M; London WB; Frazier AL; Womer RB; Rescorla F; Billmire DF; Davis MM; Perlman EJ; Giller R; Lauer SJ; Olson TA;
    Cancer; 2005 Aug; 104(4):841-7. PubMed ID: 15999362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188).
    Gradishar WJ; Stephenson P; Glover DJ; Neuberg DS; Moore MR; Windschitl HE; Piel I; Abeloff MD
    Cancer; 2001 Nov; 92(10):2517-22. PubMed ID: 11745184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
    Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.